Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.

Peeter KarihtalaSuvi-Katri LeivonenUlla PuistolaElina UrpilainenAnniina JääskeläinenSirpa LeppäArja Jukkola

Published in: Breast cancer research : BCR (2024)

Inflammation and immunity-related serum proteins have the potential to rise above the classical prognostic factors of early-stage breast cancer. They may also help to distinguish benign from malignant breast lesions.

Keyphrases

prognostic factors
early stage
early breast cancer
oxidative stress
single cell
risk assessment
radiation therapy
free survival
binding protein
human health
lymph node
small molecule
climate change
drug induced
breast cancer risk